for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Banca Farmafactoring SpA

BFF.MI

Latest Trade

5.01EUR

Change

-0.14(-2.72%)

Volume

383,007

Today's Range

4.97

 - 

5.19

52 Week Range

4.04

 - 

6.15

As of on the Italian SE (Mercato Continuo Italia) ∙ Minimum 15 minute delay

Pricing

Previous Close
5.15
Open
5.19
Volume
383,007
3M AVG Volume
9.48
Today's High
5.19
Today's Low
4.97
52 Week High
6.15
52 Week Low
4.04
Shares Out (MIL)
170.32
Market Cap (MIL)
878.84
Forward P/E
8.35
Dividend (Yield %)
--

Next Event

Q3 2020 Banca Farmafactoring SpA Earnings Release

Latest Developments

More

BFF Says Golden Power Decree Does Not Contain Prescriptions Impeding Acquisition Of DEPObank

BFF Approves Merger Of Depobank, Exchange Ratio Of 4,2233377 BFF Shares For Each Depobank Share

Banca Farmafactoring Completes Buyback Programme, Reports 0.306% Stake Acquired

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Banca Farmafactoring SpA

Banca Farmafactoring SpA is an Italy-based company primarily engaged in the corporate financial services. The Company specializes in managing and selling receivables due the National Health Service and the Public Administration. Its service portfolio comprises: credit management, debt recovery, business accounting, online invoicing, non-recourse factoring, as well as factoring with recourse, among others. It also offers online banking products, such as deposit accounts. The Company operates in Italy, Spain, Portugal, Poland, Czech Republic, and Slovak Republic. The Company operates through subsidiaries: Farmafactoring Espana SA, Farmafactoring SPV I Srl and the companies of the Magellan Group.

Industry

Consumer Financial Services

Contact Info

Via Domenichino, 5

20149

Italy

+39.02.49905458

http://www.bancafarmafactoring.it/

Executive Leadership

Salvatore Messina

Non-Executive Independent Chairman of the Board

Massimiliano Belingheri

Chief Executive Officer, Executive Director

Federico Fornari Luswergh

Non-Executive Independent Vice Chairman of the Board

Carlo Maurizio Zanni

Financial Reporting Officer

Ben Carlton Langworthy

Non-Executive Director

Key Stats

1.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2017

0.2K

2018

0.2K

2019

0.2K

2020(E)

0.2K
EPS (EUR)

2017

0.490

2018

0.542

2019

0.520

2020(E)

0.617
Price To Earnings (TTM)
9.69
Price To Sales (TTM)
4.13
Price To Book (MRQ)
2.22
Price To Cash Flow (TTM)
8.77
Total Debt To Equity (MRQ)
252.18
LT Debt To Equity (MRQ)
252.18
Return on Investment (TTM)
--
Return on Equity (TTM)
1.91

Latest News

Latest News

Italy's BFF to merge with DEPObank after deal with private equity

Italy's Banca Farmafactoring (BFF) <BFF.MI> plans to merge with depositary bank DEPObank, which it said it has agreed to buy from a group of private equity firms, lifting the specialised lender's shares on Wednesday.

BRIEF-BFF Banking Group: New Lock-up By Certain Managers Of Banca Farmafactoring S.p.A.

* BFF LUXEMBOURG S.À R.L. ENTERED WITH CEO OF BANCA FARMAFACTORING S.P.A. AND OTHER SIX MANAGERS IN LOCK-UP AGREEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Banca Farmafactoring Secondary ABO Orders Below €5.75 Per Share Risk Missing - Bookrunner

* BLOCK TRADE - BANCA FARMAFACTORING S.P.A.: BOOKRUNNER SAYS SECONDARY ABO ORDERS BELOW €5.75 PER SHARE RISK MISSING

BRIEF-Banca Farmafactoring Secondary Accelerated Bookbuilt Offering ‍Books - Bookrunner

* BLOCK TRADE - BANCA FARMAFACTORING S.P.A.: BOOKRUNNER SAYS SECONDARY ACCELERATED BOOKBUILT OFFERING BOOKS ARE COVERED, PRICE GUIDANCE TO FOLLOW Further company coverage:

BRIEF-Banca Farmafactoring 9-month net profit up at EUR 68.3 mln

* 9-MONTH NET PROFIT EUR 68.3 MILLION VERSUS EUR 41.0 MILLION A YEAR AGO

BRIEF-Banca Farmafactoring completes first acquisition of receivables in Greece

* COMPLETES ACQUISITION OF PORTFOLIO OF CREDITS TOWARDS PUBLIC HOSPITALS IN GREECE

BRIEF-Banca Farmafactoring H1 net profit up at EUR 50.7 mln

* H1 NET PROFIT EUR 50.7 MILLION VERSUS EUR 28.3 MILLION YEAR AGO

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up